TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP619	Type II interferon signaling (IFNG)	1.70224986690226e-05	-10.9809746377786	37	3	0.375	8	5311	4938,9636,3433	OAS1,ISG15,IFIT2
WP334	GPCRs, Class B Secretin-like	0.0356078460216336	-3.3351892715412	24	1	0.125	8	5311	22859	ADGRL1
WP2272	Pathogenic Escherichia coli infection	0.079956293093682	-2.5262751299333	55	1	0.125	8	5311	7846	TUBA1A
WP3865	RIG-I-like Receptor Signaling	0.0883305805320458	-2.42666890593779	61	1	0.125	8	5311	9636	ISG15
WP474	Endochondral Ossification	0.0938763153762407	-2.36577715699877	65	1	0.125	8	5311	1515	CTSV
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	0.0980162230967033	-2.322622272209	68	1	0.125	8	5311	10645	CAMKK2
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.100766958282941	-2.29494477189343	70	1	0.125	8	5311	7846	TUBA1A
WP702	Metapathway biotransformation	0.237644583761136	-1.4369790670039	177	1	0.125	8	5311	90161	HS6ST2
WP288	NLR Proteins	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP3585	Cytosine methylation	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP3674	Tgif disruption of Shh signaling	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP3297	EV release from cardiac cells and their functional effects	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP531	Mismatch repair	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP561	Heme Biosynthesis	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP696	Benzo(a)pyrene metabolism	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP3875	ATR Signaling	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP3300	Dual hijack model of Vif in HIV infection	0.999999999991063	-8.93726328726971e-12	9	0	0	8	5311
WP428	Wnt Signaling Pathway	0.999999999991681	-8.31859569829312e-12	70	0	0	8	5311
WP2889	Oxytocin signaling	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP897	Androgen receptor signaling pathway	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP2491	Diclofenac Metabolic Pathway	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP690	Polyol Pathway	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP2253	Pilocytic astrocytoma	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP3633	Caffeine and Theobromine metabolism	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP733	Serotonin Receptor 2 and STAT3 Signaling	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP521	Amino acid conjugation of benzoic acid	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP1603	Nicotine Activity on Chromaffin Cells	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP1133	Androgen receptor signaling pathway	0.999999999992431	-7.5690512588056e-12	4	0	0	8	5311
WP322	Osteoblast Signaling	0.999999999993976	-6.02380656850268e-12	14	0	0	8	5311
WP2436	Dopamine metabolism	0.999999999993976	-6.02380656850268e-12	14	0	0	8	5311
WP3853	ERK Pathway in Huntington's Disease	0.999999999993976	-6.02380656850268e-12	14	0	0	8	5311
WP229	Irinotecan Pathway	0.999999999993976	-6.02380656850268e-12	14	0	0	8	5311
WP170	Nuclear Receptors	0.999999999995357	-4.64322798939068e-12	39	0	0	8	5311
WP2355	Corticotropin-releasing hormone signaling pathway	0.999999999995997	-4.00327709251129e-12	93	0	0	8	5311
WP1530	miRNA Regulation of DNA Damage Response	0.999999999995997	-4.00327709251129e-12	93	0	0	8	5311
WP236	Adipogenesis	0.99999999999617	-3.83048238266632e-12	131	0	0	8	5311
WP615	Senescence and Autophagy in Cancer	0.999999999996193	-3.80743084189351e-12	106	0	0	8	5311
WP399	Wnt Signaling Pathway and Pluripotency	0.999999999996193	-3.80743084189351e-12	106	0	0	8	5311
WP1544	MicroRNAs in cardiomyocyte hypertrophy	0.999999999997271	-2.72898656689238e-12	102	0	0	8	5311
WP2064	Neural Crest Differentiation	0.999999999997271	-2.72898656689238e-12	102	0	0	8	5311
WP1984	Integrated Breast Cancer Pathway	0.999999999997785	-2.2148664859494e-12	154	0	0	8	5311
WP2874	Liver X Receptor Pathway	0.999999999998322	-1.67810311686533e-12	10	0	0	8	5311
WP2333	Trans-sulfuration pathway	0.999999999998322	-1.67810311686533e-12	10	0	0	8	5311
WP496	Steroid Biosynthesis	0.999999999998322	-1.67810311686533e-12	10	0	0	8	5311
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	0.999999999998322	-1.67810311686533e-12	10	0	0	8	5311
WP3601	Composition of Lipid Particles	0.999999999998322	-1.67810311686533e-12	10	0	0	8	5311
WP704	Methylation Pathways	0.999999999998322	-1.67810311686533e-12	10	0	0	8	5311
WP2113	Type III interferon signaling	0.999999999998322	-1.67810311686533e-12	10	0	0	8	5311
WP1531	Vitamin D Metabolism	0.999999999998322	-1.67810311686533e-12	10	0	0	8	5311
WP51	Regulation of Actin Cytoskeleton	0.999999999998503	-1.49745738722737e-12	149	0	0	8	5311
WP2857	Mesodermal Commitment Pathway	0.999999999998614	-1.38580855365098e-12	156	0	0	8	5311
WP2249	Metastatic brain tumor	0.999999999998642	-1.35832746763923e-12	28	0	0	8	5311
WP2361	Gastric Cancer Network 1	0.999999999998642	-1.35832746763923e-12	28	0	0	8	5311
WP98	Prostaglandin Synthesis and Regulation	0.999999999998745	-1.25522056038857e-12	30	0	0	8	5311
WP2855	Dopaminergic Neurogenesis	0.999999999998745	-1.25522056038857e-12	30	0	0	8	5311
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	0.999999999998745	-1.25522056038857e-12	30	0	0	8	5311
WP129	Matrix Metalloproteinases	0.999999999998745	-1.25522056038857e-12	30	0	0	8	5311
WP2870	Extracellular vesicle-mediated signaling in recipient cells	0.999999999998745	-1.25522056038857e-12	30	0	0	8	5311
WP241	One Carbon Metabolism	0.999999999998745	-1.25522056038857e-12	30	0	0	8	5311
WP3851	TLR4 Signaling and Tolerance	0.999999999998745	-1.25522056038857e-12	30	0	0	8	5311
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.999999999998747	-1.25267645087612e-12	144	0	0	8	5311
WP1528	Physiological and Pathological Hypertrophy  of the Heart	0.999999999998929	-1.07146673610758e-12	25	0	0	8	5311
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	0.999999999998929	-1.07146673610758e-12	25	0	0	8	5311
WP205	IL-7 Signaling Pathway	0.999999999998929	-1.07146673610758e-12	25	0	0	8	5311
WP2865	IL1 and megakaryocytes in obesity	0.999999999998929	-1.07146673610758e-12	25	0	0	8	5311
WP2895	Differentiation of white and brown adipocyte	0.999999999998929	-1.07146673610758e-12	25	0	0	8	5311
WP560	TGF-beta Receptor Signaling	0.999999999999076	-9.24371253243506e-13	58	0	0	8	5311
WP455	GPCRs, Class A Rhodopsin-like	0.999999999999359	-6.41408876818964e-13	259	0	0	8	5311
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	1.00000000000001	1.22547798080972e-14	91	0	0	8	5311
WP3925	Amino Acid metabolism	1.00000000000001	1.22547798080972e-14	91	0	0	8	5311
WP536	Calcium Regulation in the Cardiac Cell	1.00000000000034	3.44055154040797e-13	151	0	0	8	5311
WP3286	Copper homeostasis	1.00000000000055	5.48954415064118e-13	54	0	0	8	5311
WP623	Oxidative phosphorylation	1.00000000000055	5.48954415064118e-13	54	0	0	8	5311
WP673	ErbB Signaling Pathway	1.00000000000055	5.48954415064118e-13	54	0	0	8	5311
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1.00000000000055	5.48954415064118e-13	54	0	0	8	5311
WP411	mRNA Processing	1.00000000000061	6.0872544316269e-13	132	0	0	8	5311
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	1.00000000000061	6.0872544316269e-13	132	0	0	8	5311
WP289	Myometrial Relaxation and Contraction Pathways	1.00000000000065	6.46698674743797e-13	158	0	0	8	5311
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1.00000000000146	1.46400380565821e-12	37	0	0	8	5311
WP1471	Target Of Rapamycin (TOR) Signaling	1.00000000000146	1.46400380565821e-12	37	0	0	8	5311
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	1.00000000000146	1.46400380565821e-12	37	0	0	8	5311
WP3529	Zinc homeostasis	1.00000000000146	1.46400380565821e-12	37	0	0	8	5311
WP80	Nucleotide GPCRs	1.00000000000166	1.65967871356027e-12	11	0	0	8	5311
WP3630	NAD metabolism, sirtuins and aging	1.00000000000166	1.65967871356027e-12	11	0	0	8	5311
WP2513	Nanoparticle triggered regulated necrosis	1.00000000000166	1.65967871356027e-12	11	0	0	8	5311
WP1455	Serotonin Transporter Activity	1.00000000000166	1.65967871356027e-12	11	0	0	8	5311
WP2854	Gene regulatory network modelling somitogenesis	1.00000000000166	1.65967871356027e-12	11	0	0	8	5311
WP111	Electron Transport Chain	1.00000000000201	2.00701911770516e-12	92	0	0	8	5311
WP363	Wnt Signaling Pathway Netpath	1.00000000000207	2.07356580490488e-12	53	0	0	8	5311
WP1533	Vitamin B12 Metabolism	1.00000000000207	2.07356580490488e-12	53	0	0	8	5311
WP107	Translation Factors	1.00000000000207	2.07356580490488e-12	53	0	0	8	5311
WP2406	Cardiac Progenitor Differentiation	1.00000000000207	2.07356580490488e-12	53	0	0	8	5311
WP3845	Canonical  and Non-canonical Notch signaling	1.00000000000226	2.2559866772127e-12	27	0	0	8	5311
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	1.00000000000226	2.2559866772127e-12	27	0	0	8	5311
WP382	MAPK Signaling Pathway	1.00000000000232	2.31552988936683e-12	170	0	0	8	5311
WP15	Selenium Micronutrient Network	1.00000000000262	2.61783072545104e-12	87	0	0	8	5311
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	1.00000000000288	2.88222212720027e-12	73	0	0	8	5311
WP179	Cell Cycle	1.00000000000293	2.93193068106266e-12	105	0	0	8	5311
WP692	Sulfation Biotransformation Reaction	1.00000000000298	2.9788888505268e-12	18	0	0	8	5311
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	1.00000000000298	2.9788888505268e-12	18	0	0	8	5311
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	1.00000000000298	2.9788888505268e-12	18	0	0	8	5311
WP3413	NOTCH1 regulation of human endothelial cell calcification	1.00000000000298	2.9788888505268e-12	18	0	0	8	5311
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	1.00000000000298	2.9788888505268e-12	18	0	0	8	5311
WP3655	Hypothetical Craniofacial Development Pathway	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP1589	Folate-Alcohol and Cancer Pathway	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP136	Phase I biotransformations, non P450	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP3407	FTO Obesity Variant Mechanism	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP2276	Glial Cell Differentiation	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP2338	miRNA Biogenesis	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP1604	Codeine and Morphine Metabolism	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP2485	NAD Biosynthesis II (from tryptophan)	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000000304	3.03908627158516e-12	8	0	0	8	5311
WP3646	Hepatitis C and Hepatocellular Carcinoma	1.00000000000306	3.05654332251099e-12	51	0	0	8	5311
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	1.00000000000306	3.05654332251099e-12	51	0	0	8	5311
WP585	Interferon type I signaling pathways	1.00000000000309	3.08769586393619e-12	55	0	0	8	5311
WP395	IL-4 Signaling Pathway	1.00000000000309	3.08769586393619e-12	55	0	0	8	5311
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	1.00000000000309	3.08769586393619e-12	55	0	0	8	5311
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	1.00000000000312	3.11751236495799e-12	23	0	0	8	5311
WP712	Estrogen signaling pathway	1.00000000000312	3.11751236495799e-12	23	0	0	8	5311
WP311	Synthesis and Degradation of Ketone Bodies	1.00000000000315	3.1484032130953e-12	5	0	0	8	5311
WP2542	Sulindac Metabolic Pathway	1.00000000000315	3.1484032130953e-12	5	0	0	8	5311
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	1.00000000000315	3.1484032130953e-12	5	0	0	8	5311
WP3596	miR-517 relationship with ARCN1 and USP1	1.00000000000315	3.1484032130953e-12	5	0	0	8	5311
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	1.00000000000315	3.1484032130953e-12	5	0	0	8	5311
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	1.00000000000315	3.1484032130953e-12	5	0	0	8	5311
WP3594	Circadian rythm related genes	1.0000000000032	3.19608156767944e-12	207	0	0	8	5311
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	1.00000000000332	3.31807459776789e-12	68	0	0	8	5311
WP3303	Rac1/Pak1/p38/MMP-2 pathway	1.00000000000332	3.31807459776789e-12	68	0	0	8	5311
WP45	G1 to S cell cycle control	1.00000000000332	3.31807459776789e-12	68	0	0	8	5311
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	1.00000000000332	3.31807459776789e-12	68	0	0	8	5311
WP286	IL-3 Signaling Pathway	1.00000000000357	3.5659171437726e-12	49	0	0	8	5311
WP410	Diurnally Regulated Genes with Circadian Orthologs	1.00000000000357	3.5659171437726e-12	49	0	0	8	5311
WP534	Glycolysis and Gluconeogenesis	1.00000000000357	3.5659171437726e-12	49	0	0	8	5311
WP437	EGF/EGFR Signaling Pathway	1.00000000000398	3.97918257812946e-12	162	0	0	8	5311
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	1.00000000000398	3.97918257812946e-12	162	0	0	8	5311
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	1.00000000000402	4.01875474960852e-12	47	0	0	8	5311
WP2875	Constitutive Androstane Receptor Pathway	1.00000000000402	4.02420254287328e-12	32	0	0	8	5311
WP2828	Bladder Cancer	1.00000000000402	4.02420254287328e-12	32	0	0	8	5311
WP727	Monoamine Transport	1.00000000000402	4.02420254287328e-12	32	0	0	8	5311
WP2525	Trans-sulfuration and one carbon metabolism	1.00000000000402	4.02420254287328e-12	32	0	0	8	5311
WP3858	Toll-like Receptor Signaling	1.00000000000402	4.02420254287328e-12	32	0	0	8	5311
WP3893	Development and heterogeneity of the ILC family	1.00000000000402	4.02420254287328e-12	32	0	0	8	5311
WP34	Ovarian Infertility Genes	1.00000000000402	4.02420254287328e-12	32	0	0	8	5311
WP405	Eukaryotic Transcription Initiation	1.00000000000411	4.11194014000833e-12	42	0	0	8	5311
WP49	IL-2 Signaling Pathway	1.00000000000411	4.11194014000833e-12	42	0	0	8	5311
WP466	DNA Replication	1.00000000000411	4.11194014000833e-12	42	0	0	8	5311
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	1.00000000000411	4.11194014000833e-12	42	0	0	8	5311
WP2636	Common Pathways Underlying Drug Addiction	1.00000000000411	4.11194014000833e-12	42	0	0	8	5311
WP2586	Aryl Hydrocarbon Receptor	1.00000000000426	4.26118180551481e-12	48	0	0	8	5311
WP2848	Differentiation Pathway	1.00000000000426	4.26118180551481e-12	48	0	0	8	5311
WP2873	Aryl Hydrocarbon Receptor Pathway	1.00000000000426	4.26118180551481e-12	48	0	0	8	5311
WP2849	Hematopoietic Stem Cell Differentiation	1.00000000000426	4.26118180551481e-12	48	0	0	8	5311
WP117	GPCRs, Other	1.00000000000432	4.31876601540704e-12	95	0	0	8	5311
WP35	G Protein Signaling Pathways	1.00000000000432	4.31876601540704e-12	95	0	0	8	5311
WP500	Glycogen Metabolism	1.00000000000456	4.56450073981728e-12	36	0	0	8	5311
WP2012	miRs in Muscle Cell Differentiation	1.00000000000456	4.56450073981728e-12	36	0	0	8	5311
WP3298	Melatonin metabolism and effects	1.00000000000456	4.56450073981728e-12	36	0	0	8	5311
WP2324	AGE/RAGE pathway	1.00000000000486	4.85996329481101e-12	66	0	0	8	5311
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	1.00000000000486	4.85996329481101e-12	66	0	0	8	5311
WP2374	Oncostatin M Signaling Pathway	1.00000000000486	4.85996329481101e-12	66	0	0	8	5311
WP183	Proteasome Degradation	1.00000000000486	4.85996329481101e-12	66	0	0	8	5311
WP2267	Synaptic Vesicle Pathway	1.00000000000497	4.96550179315485e-12	52	0	0	8	5311
WP3676	BDNF-TrkB Signaling	1.00000000000509	5.09346626695846e-12	33	0	0	8	5311
WP453	Inflammatory Response Pathway	1.00000000000509	5.09346626695846e-12	33	0	0	8	5311
WP2197	Endothelin Pathways	1.00000000000509	5.09346626695846e-12	33	0	0	8	5311
WP58	Monoamine GPCRs	1.00000000000509	5.09346626695846e-12	33	0	0	8	5311
WP2363	Gastric Cancer Network 2	1.00000000000509	5.09346626695846e-12	33	0	0	8	5311
WP430	Statin Pathway	1.00000000000509	5.09346626695846e-12	33	0	0	8	5311
WP691	Tamoxifen metabolism	1.0000000000053	5.29718228505977e-12	21	0	0	8	5311
WP2507	Nanomaterial induced apoptosis	1.0000000000053	5.29718228505977e-12	21	0	0	8	5311
WP1602	Nicotine Activity on Dopaminergic Neurons	1.0000000000053	5.29718228505977e-12	21	0	0	8	5311
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	1.0000000000053	5.29718228505977e-12	21	0	0	8	5311
WP2533	Glycerophospholipid Biosynthetic Pathway	1.0000000000053	5.29718228505977e-12	21	0	0	8	5311
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	1.00000000000541	5.41243236370504e-12	35	0	0	8	5311
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1.00000000000541	5.41243236370504e-12	35	0	0	8	5311
WP244	Alpha 6 Beta 4 signaling pathway	1.00000000000541	5.41243236370504e-12	35	0	0	8	5311
WP2332	Interleukin-11 Signaling Pathway	1.00000000000545	5.44826128538648e-12	44	0	0	8	5311
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	1.00000000000545	5.44826128538648e-12	44	0	0	8	5311
WP716	Vitamin A and Carotenoid Metabolism	1.00000000000545	5.44826128538648e-12	44	0	0	8	5311
WP23	B Cell Receptor Signaling Pathway	1.0000000000055	5.49539405945013e-12	98	0	0	8	5311
WP1422	Sphingolipid Metabolism	1.00000000000551	5.51191009400352e-12	20	0	0	8	5311
WP516	Hypertrophy Model	1.00000000000551	5.51191009400352e-12	20	0	0	8	5311
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	1.00000000000551	5.51191009400352e-12	20	0	0	8	5311
WP391	Mitochondrial Gene Expression	1.00000000000551	5.51191009400352e-12	20	0	0	8	5311
WP1742	TP53 Network	1.00000000000551	5.51191009400352e-12	20	0	0	8	5311
WP497	Urea cycle and metabolism of amino groups	1.00000000000551	5.51191009400352e-12	20	0	0	8	5311
WP143	Fatty Acid Beta Oxidation	1.0000000000061	6.10384688784032e-12	34	0	0	8	5311
WP1601	Fluoropyrimidine Activity	1.0000000000061	6.10384688784032e-12	34	0	0	8	5311
WP313	Signaling of Hepatocyte Growth Factor Receptor	1.0000000000061	6.10384688784032e-12	34	0	0	8	5311
WP400	p38 MAPK Signaling Pathway	1.0000000000061	6.10384688784032e-12	34	0	0	8	5311
WP1591	Heart Development	1.0000000000062	6.20322980082995e-12	46	0	0	8	5311
WP465	Tryptophan metabolism	1.0000000000062	6.20322980082995e-12	46	0	0	8	5311
WP28	Selenium Metabolism and Selenoproteins	1.0000000000062	6.20322980082995e-12	46	0	0	8	5311
WP1971	Integrated Cancer Pathway	1.0000000000062	6.20322980082995e-12	46	0	0	8	5311
WP3878	ATM Signaling Network in Development and Disease	1.0000000000062	6.20322980082995e-12	46	0	0	8	5311
WP268	Notch Signaling Pathway	1.0000000000062	6.20322980082995e-12	46	0	0	8	5311
WP306	Focal Adhesion	1.00000000000665	6.6544426388774e-12	195	0	0	8	5311
WP438	Non-homologous end joining	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP2805	RNA interference	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP528	Acetylcholine Synthesis	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP1310	Selenium Micronutrient Network	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP699	Aflatoxin B1 metabolism	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP1995	Effects of Nitric Oxide	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP2596	Gastric acid production	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP134	Pentose Phosphate Pathway	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP3595	mir-124 predicted interactions with cell cycle and differentiation	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP3924	Hfe effect on hepcidin production	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP1272	Selenium Micronutrient Network	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	1.0000000000067	6.70397655645195e-12	7	0	0	8	5311
WP481	Insulin Signaling	1.00000000000689	6.89416367779303e-12	161	0	0	8	5311
WP1539	Angiogenesis	1.00000000000714	7.13529306863218e-12	24	0	0	8	5311
WP262	EBV LMP1 signaling	1.00000000000714	7.13529306863218e-12	24	0	0	8	5311
WP2509	Nanoparticle triggered autophagic cell death	1.00000000000714	7.13529306863218e-12	24	0	0	8	5311
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	1.00000000000714	7.13529306863218e-12	24	0	0	8	5311
WP2911	miRNA targets in ECM and membrane receptors	1.00000000000728	7.28275254548669e-12	43	0	0	8	5311
WP364	IL-6 signaling pathway	1.00000000000728	7.28275254548669e-12	43	0	0	8	5311
WP2377	Integrated Pancreatic Cancer Pathway	1.00000000000729	7.29230671267695e-12	197	0	0	8	5311
WP2328	Allograft Rejection	1.0000000000073	7.30334122051012e-12	80	0	0	8	5311
WP2034	Leptin signaling pathway	1.00000000000731	7.30602770936492e-12	76	0	0	8	5311
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	1.00000000000731	7.30602770936492e-12	76	0	0	8	5311
WP2037	Prolactin Signaling Pathway	1.00000000000731	7.30602770936492e-12	76	0	0	8	5311
WP2878	PPAR Alpha Pathway	1.00000000000752	7.52245011639096e-12	26	0	0	8	5311
WP325	Triacylglyceride Synthesis	1.00000000000752	7.52245011639096e-12	26	0	0	8	5311
WP530	Cytokines and Inflammatory Response	1.00000000000752	7.52245011639096e-12	26	0	0	8	5311
WP581	EPO Receptor Signaling	1.00000000000752	7.52245011639096e-12	26	0	0	8	5311
WP26	Signal Transduction of S1P Receptor	1.00000000000752	7.52245011639096e-12	26	0	0	8	5311
WP698	Glucuronidation	1.00000000000752	7.52245011639096e-12	26	0	0	8	5311
WP185	Integrin-mediated Cell Adhesion	1.00000000000774	7.73714724510312e-12	103	0	0	8	5311
WP75	Toll-like Receptor Signaling Pathway	1.00000000000774	7.73714724510312e-12	103	0	0	8	5311
WP195	IL-1 signaling pathway	1.000000000008	8.00020374688791e-12	57	0	0	8	5311
WP2795	Cardiac Hypertrophic Response	1.000000000008	8.00020374688791e-12	57	0	0	8	5311
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP3644	NAD+ metabolism	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP12	Osteoclast Signaling	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP550	Biogenic Amine Synthesis	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP53	ID signaling pathway	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP47	Hedgehog Signaling Pathway	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP1946	Cori Cycle	1.000000000008	8.00229214530626e-12	16	0	0	8	5311
WP2261	Signaling Pathways in Glioblastoma	1.00000000000807	8.06965587445495e-12	83	0	0	8	5311
WP2371	Parkinsons Disease Pathway	1.00000000000807	8.06965587445495e-12	83	0	0	8	5311
WP707	DNA Damage Response	1.00000000000823	8.22978863637045e-12	69	0	0	8	5311
WP2369	Histone Modifications	1.00000000000823	8.22978863637045e-12	69	0	0	8	5311
WP176	Folate Metabolism	1.00000000000823	8.22978863637045e-12	69	0	0	8	5311
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	1.00000000000831	8.30923299346562e-12	41	0	0	8	5311
WP2858	Ectoderm Differentiation	1.0000000000084	8.39973084346023e-12	143	0	0	8	5311
WP2884	NRF2 pathway	1.0000000000084	8.39973084346023e-12	143	0	0	8	5311
WP558	Complement and Coagulation Cascades	1.00000000000851	8.50537198888142e-12	60	0	0	8	5311
WP3527	Preimplantation Embryo	1.00000000000851	8.50537198888142e-12	60	0	0	8	5311
WP304	Kit receptor signaling pathway	1.00000000000851	8.50537198888142e-12	60	0	0	8	5311
WP231	TNF alpha Signaling Pathway	1.00000000000866	8.65578192797656e-12	94	0	0	8	5311
WP1772	Apoptosis Modulation and Signaling	1.00000000000866	8.65578192797656e-12	94	0	0	8	5311
WP138	Androgen receptor signaling pathway	1.00000000000866	8.65710836340556e-12	90	0	0	8	5311
WP477	Cytoplasmic Ribosomal Proteins	1.00000000000866	8.65710836340556e-12	90	0	0	8	5311
WP3613	Photodynamic therapy-induced unfolded protein response	1.00000000000868	8.67592851348548e-12	29	0	0	8	5311
WP2643	Nanoparticle-mediated activation of receptor signaling	1.00000000000868	8.67592851348548e-12	29	0	0	8	5311
WP422	MAPK Cascade	1.00000000000868	8.67592851348548e-12	29	0	0	8	5311
WP2583	T-Cell Receptor and Co-stimulatory Signaling	1.00000000000868	8.67592851348548e-12	29	0	0	8	5311
WP2059	Alzheimers Disease	1.00000000000884	8.84377282762215e-12	148	0	0	8	5311
WP710	DNA Damage Response (only ATM dependent)	1.00000000000893	8.92838550723063e-12	114	0	0	8	5311
WP3408	Evolocumab Mechanism	1.00000000000946	9.45533533544003e-12	3	0	0	8	5311
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	1.00000000000946	9.45533533544003e-12	3	0	0	8	5311
WP254	Apoptosis	1.00000000000963	9.62637780022875e-12	86	0	0	8	5311
WP545	Complement Activation	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP100	Glutathione metabolism	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP357	Fatty Acid Biosynthesis	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP272	Blood Clotting Cascade	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP3599	Transcription factor regulation in adipogenesis	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP167	Eicosanoid Synthesis	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP1584	Type II diabetes mellitus	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP3645	NAD+ biosynthetic pathways	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP1424	Globo Sphingolipid Metabolism	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	1.00000000000971	9.71351201156033e-12	22	0	0	8	5311
WP197	Cholesterol Biosynthesis	1.00000000001	9.9993174409322e-12	15	0	0	8	5311
WP206	Fatty Acid Omega Oxidation	1.00000000001	9.9993174409322e-12	15	0	0	8	5311
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000001	9.9993174409322e-12	15	0	0	8	5311
WP3	Transcriptional activation by NRF2	1.00000000001	9.9993174409322e-12	15	0	0	8	5311
WP2431	Spinal Cord Injury	1.00000000001031	1.03097900804405e-11	119	0	0	8	5311
WP1981	Thyroxine (Thyroid Hormone) Production	1.00000000001087	1.08734203242945e-11	6	0	0	8	5311
WP694	Arylamine metabolism	1.00000000001087	1.08734203242945e-11	6	0	0	8	5311
WP1600	Nicotine Metabolism	1.00000000001087	1.08734203242945e-11	6	0	0	8	5311
WP3891	Benzene metabolism	1.00000000001087	1.08734203242945e-11	6	0	0	8	5311
WP366	TGF-beta Signaling Pathway	1.00000000001093	1.09279780890775e-11	133	0	0	8	5311
WP2536	Colchicine Metabolic Pathway	1.00000000001123	1.12282596415048e-11	1	0	0	8	5311
WP188	Focal Adhesion	1.00000000001123	1.12282596415048e-11	1	0	0	8	5311
WP1	Statin Pathway	1.00000000001123	1.12282596415048e-11	1	0	0	8	5311
WP661	Glucose Homeostasis	1.00000000001123	1.12282596415048e-11	1	0	0	8	5311
WP2190	One carbon donor	1.00000000001123	1.12282596415048e-11	1	0	0	8	5311
WP3191	TSLP Signaling Pathway	1.00000000001123	1.12282596415048e-11	1	0	0	8	5311
WP3627	Gut-Liver Indole Metabolism	1.00000000001123	1.12282596415048e-11	1	0	0	8	5311
WP108	Selenium metabolism/Selenoproteins	1.00000000001123	1.12282596415048e-11	1	0	0	8	5311
WP404	Nucleotide Metabolism	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP1992	TarBasePathway	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP3287	Overview of nanoparticle effects	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP247	Small Ligand GPCRs	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP697	Estrogen metabolism	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP2879	Farnesoid X Receptor  Pathway	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP22	IL-9 Signaling Pathway	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP384	Apoptosis Modulation by HSP70	1.00000000001159	1.15900323379959e-11	19	0	0	8	5311
WP3892	Development of pulmonary dendritic cells and macrophage subsets	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP2881	Estrogen Receptor Pathway	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP1423	Ganglio Sphingolipid Metabolism	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP1434	Osteopontin Signaling	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP186	Homologous recombination	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP3871	Valproic acid pathway	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	1.00000000001164	1.16418092880839e-11	13	0	0	8	5311
WP2516	ATM Signaling Pathway	1.00000000001225	1.22541481040661e-11	40	0	0	8	5311
WP524	G13 Signaling Pathway	1.00000000001225	1.22541481040661e-11	40	0	0	8	5311
WP127	IL-5 Signaling Pathway	1.00000000001225	1.22541481040661e-11	40	0	0	8	5311
WP1449	Regulation of toll-like receptor signaling pathway	1.00000000001254	1.25379646697889e-11	145	0	0	8	5311
WP2853	Endoderm Differentiation	1.00000000001254	1.25379646697889e-11	145	0	0	8	5311
WP1273	Folic Acid Network	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP2816	Felbamate Metabolism	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP2943	Hypoxia-mediated EMT and Stemness	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP2646	Lidocaine metabolism	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP1438	Influenza A virus infection	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP1311	Folic Acid Network	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP2366	Butyrate-induced histone acetylation	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP2866	mir34a and TGIF2 in osteoclastogenesis	1.00000000001261	1.26067427261222e-11	2	0	0	8	5311
WP2637	Structural Pathway of Interleukin 1 (IL-1)	1.00000000001326	1.32555181036381e-11	50	0	0	8	5311
WP1545	miRNAs involved in DNA damage response	1.00000000001326	1.32555181036381e-11	50	0	0	8	5311
WP2446	Retinoblastoma (RB) in Cancer	1.00000000001337	1.33693426626476e-11	88	0	0	8	5311
WP2029	Cell Differentiation - Index	1.00000000001337	1.33699462735777e-11	38	0	0	8	5311
WP383	Striated Muscle Contraction	1.00000000001337	1.33699462735777e-11	38	0	0	8	5311
WP2447	Amyotrophic lateral sclerosis (ALS)	1.00000000001337	1.33699462735777e-11	38	0	0	8	5311
WP2526	PDGF Pathway	1.00000000001337	1.33699462735777e-11	38	0	0	8	5311
WP61	Notch Signaling Pathway	1.00000000001397	1.39749192752478e-11	62	0	0	8	5311
WP3584	MECP2 and Associated Rett Syndrome	1.00000000001397	1.39749192752478e-11	62	0	0	8	5311
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	1.00000000001397	1.39749192752478e-11	62	0	0	8	5311
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	1.00000000001442	1.44151011486105e-11	74	0	0	8	5311
WP24	Peptide GPCRs	1.00000000001442	1.44151011486105e-11	74	0	0	8	5311
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1.00000000001497	1.49727764186314e-11	31	0	0	8	5311
WP2112	IL17 signaling pathway	1.00000000001497	1.49727764186314e-11	31	0	0	8	5311
WP408	Oxidative Stress	1.00000000001497	1.49727764186314e-11	31	0	0	8	5311
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	1.00000000001529	1.52919333928678e-11	17	0	0	8	5311
WP78	TCA Cycle	1.00000000001529	1.52919333928678e-11	17	0	0	8	5311
WP554	ACE Inhibitor Pathway	1.00000000001529	1.52919333928678e-11	17	0	0	8	5311
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	1.00000000001529	1.52919333928678e-11	17	0	0	8	5311
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	1.00000000001529	1.52919333928678e-11	17	0	0	8	5311
WP2289	Drug Induction of Bile Acid Pathway	1.00000000001529	1.52919333928678e-11	17	0	0	8	5311
WP3874	Canonical and Non-Canonical TGF-B signaling	1.00000000001529	1.52919333928678e-11	17	0	0	8	5311
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1.000000000021	2.10003648081637e-11	12	0	0	8	5311
WP2007	Iron metabolism in placenta	1.000000000021	2.10003648081637e-11	12	0	0	8	5311
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	1.000000000021	2.10003648081637e-11	12	0	0	8	5311
WP106	Alanine and aspartate metabolism	1.000000000021	2.10003648081637e-11	12	0	0	8	5311
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	1.000000000021	2.10003648081637e-11	12	0	0	8	5311
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	1.000000000021	2.10003648081637e-11	12	0	0	8	5311
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	1.000000000021	2.10003648081637e-11	12	0	0	8	5311
WP2290	RalA downstream regulated genes	1.000000000021	2.10003648081637e-11	12	0	0	8	5311
WP3624	Lung fibrosis	1.00000000002139	2.1389302082791e-11	63	0	0	8	5311
WP43	Oxidation by Cytochrome P450	1.00000000002139	2.1389302082791e-11	63	0	0	8	5311
